Cooper Companies | COO - Market Capitalization


Cooper Companies reported $12.49B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Align Technology USD 10.33B 1.75B Sep/2026
AtriCure USD 2.95B 90M Nov/2026
Bausch Health Companies USD 4.13B 1.95B Nov/2026
Baxter International USD 12.41B 1.4B Sep/2026
Bayer EUR 52.42B 5.31B Nov/2026
Becton, Dickinson and Co. USD 61.93B 13.17B Nov/2026
Boston Scientific USD 63.6B 337M Nov/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Dentsply International USD 2.09B 326M Nov/2026
Dexcom USD 32.56B 6.57B Sep/2026
Edwards Lifesciences USD 58.61B 8.86B Nov/2026
Globus Medical USD 11.02B 969M Nov/2026
Haemonetics USD 6.3B 1.51B Nov/2026
Insulet USD 11.54B 2.49B Nov/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
Intuitive Surgical USD 143.65B 2.81B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.15B 1.01B Sep/2026
Novartis USD 328.21B 54.92B Nov/2026
ResMed USD 28.27B 4.43B Jun/2026
STAAR Surgical USD 1.33B 200M Nov/2026
Steris USD 24.5B 4.02B Nov/2026
Stryker USD 105.63B 15.07B Sep/2026
Tandem Diabetes Care USD 1.18B 46M Nov/2026
Teleflex USD 7.16B 1.86B Nov/2026
Utah Medical Products USD 197M 19M Mar/2026
Zimmer Biomet Holdings USD 22.63B 5.69B Nov/2026